Translate
Agenus Inc
About
Agenus Inc (NASDAQ:AGEN) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 21 2026
Agenus Names BAP Pharma as Exclusive Global Partner for BOT+BAL Access Programs
Apr 17 2026
Agenus Reports Phase II Data Demonstrating Immune Reprogramming and Durable Survival with Botensilimab, Balstilimab and agenT-797 in PD-1 Refractory Gastroesophageal Cancer
Apr 3 2026
Agenus Announces Data from Phase II Study of BOT+BAL in Combination with agent-797 in PD-1 Refractory Gastroesophageal Cancer to be Presented at AACR 2026
Apr 1 2026
Agenus Announces First Patient Enrolled in Global Phase 3 BATTMAN Trial of BOT+BAL Immunotherapy Combination in MSS or pMMR Metastatic Colorectal Cancer
Mar 26 2026
Agenus to Host March 2026 Stakeholder Webcast Harnessing the Immune System to Advance BOT + BAL Across Tumor Types and Expand Patient Access